Additionally, the animals treated with NKG2D CAR-T cells showed no significant body weight loss or other xenogeneic graft-versus-host disease (x-GVHD) symptoms compared with those in the CD19 CAR-T, UNT cells and saline-treated groups (Figure 4E). Here, KLRK1 is linked to graft versus host disease.